Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $168.56 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $55.87 | 2 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $24.37 | 1 | $0 (2017) |
| PFIZER INC. | $22.90 | 1 | $0 (2022) |
| Ipsen Biopharmaceuticals, Inc | $18.71 | 1 | $0 (2017) |
| Taiho Oncology, Inc. | $12.06 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $12.03 | 1 | $0 (2018) |
| GENZYME CORPORATION | $11.80 | 1 | $0 (2019) |
| Amgen Inc. | $10.82 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.92 | 1 | AstraZeneca Pharmaceuticals LP ($18.92) |
| 2022 | $22.90 | 1 | PFIZER INC. ($22.90) |
| 2019 | $59.57 | 3 | AstraZeneca Pharmaceuticals LP ($36.95) |
| 2018 | $24.09 | 2 | Taiho Oncology, Inc. ($12.06) |
| 2017 | $43.08 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($24.37) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/15/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Oncology | ||||||
| 02/08/2022 | PFIZER INC. | XALKORI (Drug), INLYTA, BAVENCIO | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2019 | Amgen Inc. | MVASI (Biological), Neulasta, Vectibix | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: Oncology | ||||||
| 06/04/2019 | GENZYME CORPORATION | GAUCHER-DISEASE (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| 05/01/2019 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $36.95 | General |
| Category: Oncology | ||||||
| 06/20/2018 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug), VOTRIENT | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: ONCOLOGY | ||||||
| 04/24/2018 | Taiho Oncology, Inc. | Lonsurf (Drug) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: Oncology | ||||||
| 11/14/2017 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Oncology | ||||||
| 05/08/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,700 | 2,652 | $545,566 | $75,875 |
| 2022 | 19 | 1,573 | 2,378 | $497,024 | $71,534 |
| 2021 | 18 | 1,449 | 2,213 | $426,722 | $63,271 |
| 2020 | 19 | 1,358 | 2,175 | $404,820 | $63,631 |
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 555 | 1,035 | $260,820 | $28,439 | 10.9% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 206 | 270 | $76,950 | $16,665 | 21.7% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 73 | 255 | $29,580 | $5,420 | 18.3% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2023 | 139 | 184 | $28,520 | $3,831 | 13.4% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 110 | 140 | $17,500 | $3,671 | 21.0% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2023 | 32 | 33 | $14,124 | $3,614 | 25.6% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2023 | 41 | 51 | $12,750 | $2,637 | 20.7% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2023 | 55 | 108 | $9,072 | $2,158 | 23.8% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 217 | 231 | $46,570 | $1,940 | 4.2% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2023 | 26 | 33 | $5,643 | $1,548 | 27.4% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Facility | 2023 | 11 | 11 | $5,129 | $1,482 | 28.9% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 19 | 36 | $5,400 | $1,138 | 21.1% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 107 | 119 | $16,898 | $1,104 | 6.5% |
| 88172 | Evaluation of fine needle aspirate | Facility | 2023 | 26 | 28 | $4,200 | $731.22 | 17.4% |
| 88333 | Pathology cytologic examination of specimen during surgery, initial site | Facility | 2023 | 12 | 13 | $1,365 | $609.96 | 44.7% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 13 | 45 | $3,780 | $409.60 | 10.8% |
| 88104 | Cell examination of body fluid, smears | Facility | 2023 | 13 | 14 | $1,470 | $288.95 | 19.7% |
| 88302 | Pathology examination of tissue using a microscope | Facility | 2023 | 21 | 21 | $2,646 | $108.36 | 4.1% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Facility | 2023 | 24 | 25 | $3,150 | $80.16 | 2.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 559 | 947 | $238,644 | $26,872 | 11.3% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 187 | 264 | $75,240 | $16,764 | 22.3% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2022 | 159 | 211 | $32,705 | $4,491 | 13.7% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 54 | 166 | $19,256 | $3,583 | 18.6% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2022 | 28 | 29 | $12,412 | $3,172 | 25.6% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 86 | 117 | $14,625 | $3,058 | 20.9% |
About Dr. Ashraf Khan, MD
Dr. Ashraf Khan, MD is a Anatomic Pathology & Clinical Pathology healthcare provider based in Lubbock, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760462279.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashraf Khan, MD has received a total of $168.56 in payments from pharmaceutical and medical device companies, with $18.92 received in 2024. These payments were reported across 9 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($168.56).
As a Medicare-enrolled provider, Khan has provided services to 6,080 Medicare beneficiaries, totaling 9,418 services with total Medicare billing of $274,311. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Location Lubbock, TX
- Active Since 01/19/2006
- Last Updated 06/18/2015
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1760462279
Products in Payments
- TAGRISSO (Drug) $36.95
- Xofigo (Drug) $24.37
- XALKORI (Drug) $22.90
- CALQUENCE (Drug) $18.92
- Onivyde (Drug) $18.71
- Lonsurf (Drug) $12.06
- AFINITOR (Drug) $12.03
- GAUCHER-DISEASE (Drug) $11.80
- MVASI (Biological) $10.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology & Clinical Pathology Doctors in Lubbock
Dr. Melissa Blann, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $32,532
Mr. Jason Loos, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $846.65
Dr. Irfan Warraich, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $580.55
Dr. Lola Windisch, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $555.69
Dr. Suzanne Graham, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $397.38
Dr. Jose Pinto, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $387.01